IndraLab

Statements


2 | 1 1

No evidence text available

reach
"In the treatment of NSCC, midostaurin inhibits TBK1, PDPK1, and AURKA at the same time, and the combined inhibition of these targets changed PI3K/AKT and cell cycle signaling pathways, which were partially concentrated on PLK1 (112)."

eidos
"In the treatment of NSCC , midostaurin inhibits TBK1 , PDPK1 , and AURKA at the same time , and the combined inhibition of these targets changed PI3K / AKT and cell cycle signaling pathways , which were partially concentrated on PLK1 ( 112 ) ."

No evidence text available